AKONNI BIOSYSTEMS INC

Profile

Company Names

AKONNI BIOSYSTEMS INC

Addresses

400 SAGNER, SUITE 300, FREDERICK, MD 21701

400 SAGNER, SUITE 300, FREDRICK, MD 21701

Phone Numbers

3015247867

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$29,059,530.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2019-06-04 
$1,775,000.00 
$4,600,000.00 
$2,825,000.00 
Debt 
10
2018-08-01 
$1,105,000.00 
$7,000,000.00 
$5,895,000.00 
Debt 
9
2018-02-07 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
8
2018-01-20 
$2,358,583.00 
$2,358,583.00 
$0.00 
Equity 
7
2017-08-22 
$2,346,182.00 
$2,346,182.00 
$0.00 
Equity 
6
2017-03-15 
$4,000,000.00 
$6,000,000.00 
$2,000,000.00 
Debt 
5
2016-04-30 
$1,315,250.00 
$5,000,000.00 
$3,684,750.00 
Debt 
4
2015-04-13 
$618,998.00 
$3,000,000.00 
$2,381,002.00 
Equity 
3
2012-01-06 
$2,127,919.00 
$20,000,000.00 
$17,872,081.00 
Equity 
2
2010-12-03 
$912,598.00 
$8,000,000.00 
$7,087,402.00 
Equity 
1
2009-02-25 
$5,000,000.00 
$6,300,000.00 
$1,300,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DARRELL 
 
CHANDLER 
EXECUTIVE OFFICER
CHARLES 
 
DAITCH 
DIRECTOR, EXECUTIVE OFFICER
JON 
 
DAVIS 
EXECUTIVE OFFICER
MICHAEL 
 
FARMER 
EXECUTIVE OFFICER, DIRECTOR
LAWRENCE 
 
FIRESTONE 
EXECUTIVE OFFICER
DR. MYUN 
 
HAN 
DIRECTOR
THOMAS 
 
HIGGINS 
DIRECTOR, EXECUTIVE OFFICER
DAVID 
 
KEYS 
DIRECTOR
BRIAN 
 
MORRA 
DIRECTOR
MICHAEL 
 
MURPHY 
EXECUTIVE OFFICER
GLEICHEN RESOURCES LTD.   |  NEXUS ENERGYHOMES, INC.   |  TMG ENERGY CORP   |  DIAMOND FOODS INC   |  TOREX GOLD RESOURCES INC.   |  3D VISION SYSTEMS LLC   |  NATIONAL GENERAL HOLDINGS CORP.   |  HOLY MOUNTAIN BREWING CO   |  AMERICAN HOTEL INCOME PROPERTIES REIT INC.   |  STACKIQ, INC.   |  KINEX PHARMACEUTICALS, INC.   |  DISTRIBU.TD, INC.   |  TRANSEASTERN POWER TRUST   |  SUN CLINICAL LABORATORY, LLC - SERIES 4   |  SUN CLINICAL LABORATORY, LLC - SERIES 3   |  SUN CLINICAL LABORATORY, LLC - SERIES 1   |  SUN CLINICAL LABORATORY, LLC - SERIES 7   |  SUN CLINICAL LABORATORY, LLC - SERIES 5   |  SUN CLINICAL LABORATORY, LLC - SERIES 10   |  SUN CLINICAL LABORATORY, LLC - SERIES 8   |  SUN CLINICAL LABORATORY, LLC - SERIES 9   |  SUN CLINICAL LABORATORY, LLC - SERIES 14   |  PROCTORFREE, INC.   |  SUN CLINICAL LABORATORY, LLC - SERIES 15   |  ROSECLIFF VENTURE PARTNERS, LP   |  AHTOVATION, INC.   |  ADVANTAGE ADVISERS XANTHUS FUND, L.L.C.   |  AKONNI BIOSYSTEMS INC   |  SUN CLINICAL LABORATORY, LLC - SERIES 29   |  ALTERNATE HEALTH CORP.   |  ROSECLIFF VENTURE PARTNERS II, LP   |  ASSABET VALLEY BANCORP   |  AMPLE HILLS HOLDINGS, INC.   |  POST.BID.SHIP., INC.   |  PROPHET ADVANTAGE PARTNERS LP   |  ETHOS GOLD CORP.   |  TENEO PARTNERS, LP   |  ROSECLIFF CREDIT OPPORTUNITY FUND I, L.P.   |  TORTOISE, INC.   |  QUISITIVE TECHNOLOGY SOLUTIONS, INC.   |  PROSPECTOR METALS CORP.   |  BATTERY METALS STREAMING CORP.   |  ANTHEM SPORTS + ENTERTAINMENT INC.   |  MICROSHARE, INC.   |  ANOKIWAVE, INC.   |  ROSECLIFF FRONTIER TECHNOLOGIES FUND I, L.P.   |  AQUILA HARTLAND HOLDINGS, LLC   |  BOOSTLY, INC.   |  SOUTH PACIFIC METALS CORP.   |  ARA LABS INC.   |  NEXT GENERATION SPV 1 LLC   |  NEXT GENERATION SPV 2 LLC   |  NEXT GENERATION SPV 3 LLC   |  WPSL PRO, LLC   |  ROSECLIFF NEXT GENERATION LLC - SERIES RSAI ACCESSS-1   |  ROSECLIFF NEXT GENERATION LLC - SERIES P ACCESS   |  ROSECLIFF NEXT GENERATION LLC - SERIES CBIO ACCESS -1   |  ROSECLIFF NEXT GENERATION LLC - SERIES PVTR ACCESS
CHUCK 
 
PARRISH 
DIRECTOR
RON 
 
PION 
EXECUTIVE OFFICER, DIRECTOR
MARY 
 
PITMAN 
DIRECTOR
MARY 
 
PITTMAN 
DIRECTOR
GEORGE 
 
RUDY 
EXECUTIVE OFFICER
DR. JIALU 
 
WU 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-03-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-04-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-04-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-02-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-02-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-02-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RBC CAPITAL MARKETS, LLC